معرفی
Halil İbrahim ERDOĞDU is an Associate Professor at Kafkas University Faculty of Medicine, Department of Internal Medicine Sciences, with a career spanning over 25 years. He previously held academic positions at İstanbul Medeniyet University (1994-1998) and completed his medical education at Dicle University in 1991, followed by medical specialization from Turkey's Ministry of Health in 1998.
- Academic Education: MD (Dicle University, 1991), Medical Specialization (Ministry of Health, 1998)
- Professional Experience: 2015- Kafkas University (Full-Time), 1994-1998 İstanbul Medeniyet University (Full-Time)
His research focuses on Hemodialysis, Vitamin D Deficiency, Metabolic Disorders, and Vaccine Response in chronic disease patients. He has led projects on COVID-19 Vaccine Response in Hemodialysis Patients (2021-2024) and Podocalyxin Levels in Prediabetic Patients (2019). His work appears in journals like Current Microbiology, Kafkas Journal of Medical Sciences, and Clinical and Experimental Nephrology.
He teaches courses on Hemodialysis, Parathyroid Disorders, Tubulointerstitial Nephritis, and Functional Bowel Diseases across multiple academic years (2016-2022). His collaborations include researchers like Eray Atalay (18 joint works), Fatih Kara (3), and Tuğba Karakaya (2).
Key publications analyze Hemodialysis Vaccine Efficacy, CRP/Albumin Ratio in STEMI Patients, and Serum Ferritin Metabolic Correlations. His YÖKSIS metrics place him among 339 Internal Medicine specialists in Turkey with significant citation impact.